Efficacy and safety of aripiprazole once-monthly versus oral aripiprazole in Chinese patients with acute schizophrenia: a multicenter, randomized, double-blind, non-inferiority study

Post time 2023-2-15 14:50:27

journal：Psychopharmacology

Authors：Le Xiao; Qian Zhao; An-ning Li; Jushui Sun; Bin Wu; Lina Wang; Honggeng Zhang; Ruiling Zhang; Keqing Li; Xiaojin Xu; Tiebang Liu; Wenshun Zhang; Shiping Xie; Xiufeng Xu; Yunlong Tan; Kerang Zhang; Hongyan Zhang; Nianhong Guan; Mingji Xian; Motomichi Uki; Gang Wang

Published date：2022-1-

DOI：10.1007/s00213-021-06044-x

Article link：http://dx.doi.org/10.1007/s00213-021-06044-x

Article Source：Springer Science and Business Media LLC。

Remark：

Post time 2023-2-15 14:50:28

: This post has been completed
Completed attachments will be deleted within 24 hours.

Post time 2023-2-15 14:52:16

: This post has been completed
Completed attachments will be deleted within 24 hours.

Post time 2023-2-15 14:54:09

: This post has been completed
Completed attachments will be deleted within 24 hours.

Post time 2023-2-15 15:00:18

: This post has been completed
Completed attachments will be deleted within 24 hours.

Post time 2023-2-15 15:00:43

: This post has been completed
Completed attachments will be deleted within 24 hours.

Efficacy and safety of aripiprazole once-monthly versus oral aripiprazole in Chinese patients with acute schizophrenia: a multicenter, randomized, double-blind, non-inferiority study

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

Efficacy and safety of aripiprazole once-monthly versus oral aripiprazole in Chinese patients with acute schizophrenia: a multicenter, randomized, double-blind, non-inferiority study Copy

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

Efficacy and safety of aripiprazole once-monthly versus oral aripiprazole in Chinese patients with acute schizophrenia: a multicenter, randomized, double-blind, non-inferiority study